What's Next for Next Pharmaceuticals? Seditol(R), a New All-Natural Dietary Supplement Turns Off Stress to Ensure a Good Night's Sleep
Posted on: Friday, 31 March 2006, 15:00 CST
Next Pharmaceuticals, Inc. (NPI) announced today that they are conducting a consumer awareness campaign on Seditol, their new dietary supplement blend of proprietary ingredients that helps to turn off stress to achieve a good night's sleep. Seditol is an all natural blend of a patented extract from Magnolia officinalis and a proprietary extract from Ziziphus spinosa. According to the US Government Health and Human Services Office of Women's Health, about 60 million Americans each year suffer from insomnia, which can lead to serious sleep deficits and problems. Insomnia tends to increase with age and affects about 40 percent of women and 30 percent of men.
Kim Cleveland, 44, was leading a very stressful life and said she was waking up many times each night. She was told it was because she was in her forties and she should expect to have insomnia due to her hormonal fluctuations. However, as a nurse, she investigated this further. She found a doctor who helped her change some lifestyle habits and recommended Seditol for her sleep disorder. She is now getting a good night's sleep after months of waking up constantly.
"Both men and women suffer from insomnia and what many don't know is that there is something that can be done about it," said Deanne Dolnick, Director of Sales, NPI. "Seditol is an effective and safe dietary supplement that is helping a lot of people who prefer a natural approach to managing their sleeplessness."
A recent study at the Sleep Research and Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine has demonstrated that the leading cause of sleeplessness in otherwise healthy adults is an overactive central nervous system with associated elevation of stress hormones. The scientists concluded from this study that the therapeutic goal in sleeplessness is to decrease the level of physical and emotional arousal, and not just improve nighttime sleep. Seditol was developed to uniquely address the need to decrease nighttime physical and emotional arousal while providing a feeling of relaxation and less worry.
A forty-five person study utilizing Seditol was conducted by an independent research organization in March, 2005. The subjects in this study reported the following results:
-- 91% said Seditol helps ensure a sound night's sleep
-- 89% said Seditol allows you to wake up feeling refreshed
-- 91% said Seditol reduces fatigue due to lack of sleep
-- 96% said Seditol is gentle to your stomach
Next Pharmaceuticals, Inc. has two patents on the Magnolia portion of Seditol(R).
About Next Pharmaceuticals, Inc.
Next Pharmaceuticals, Inc. is a research and development company that markets its patented or patent-pending ingredients such as Relora(R), Nexrutine(R), Seditol(R) and Citri-Z(TM) to food, beverage, and dietary supplement companies seeking differentiation and a marketing edge with their healthy living products.
Source: Business Wire
Related Articles
- Lack Of Sleep May Be More Dangerous For Women Than Men
- China Potassium Sulfate Market Study Research Report Provides Estimations and Analysis on China's Potassium Sulfate Market for 2007-2008
- Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
- BioSante Pharmaceuticals to Present LibiGel(R) at International Society for the Study of Women's Sexual Health (ISSWSH) Annual Meeting
- Study: Anti-Aging Supplements Don't Work
- Cyveillance Outlines Best Practices for Combating Illegal Online Pharmaceutical Distribution; New Research Provides Counter-Measures for Limiting Exposure and Risk
- BioSante Pharmaceuticals Presents Bio-E-Gel(TM) Data at The International Society for the Study of Women's Sexual Health Annual Meeting
- Air Pollutants May Warm Winter Nights in China: Study
- BioSante Pharmaceuticals to Present at International Society for the Study of Women's Sexual Health and Sachs Biotech Conferences
- Highlights From the Journal SLEEP Focus on Insomnia in Women andSleep Problems Related to Both Shift Work, Abortion
User Comments (0)

RSS Feeds